---

$29.26

+0.1360 ( +0.47% ) 2.4M

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-02-05	Sale	-22859.00	Barry Douglas
2024-02-05	Sale	-87168.00	Weber Barbara
2024-02-05	Sale	-46599.00	Crystal Adam
2024-02-05	Sale	-39413.00	Beckman Daniella
2023-11-02	Sale	-7507.00	Crystal Adam
2023-10-17	Buy	750000.00	Boxer Capital, LLC
2023-10-11	Sale	-50000.00	Boxer Capital, LLC
2023-08-31	Sale	-10000.00	Ketchum John B
2023-08-15	Buy	475000.00	Boxer Capital, LLC